These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8900347)

  • 1. Benefits of maternal serum alpha-fetoprotein testing.
    Dyson RD
    Am Fam Physician; 1996 Nov; 54(6):1890, 1893. PubMed ID: 8900347
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alpha-1-fetoprotein in the amniotic fluid and blood of pregnant women].
    Zizkovský V; Koubová J; Havranová M; Chudý D; Fuchs V
    Cesk Gynekol; 1988 Jun; 53(5):330-9. PubMed ID: 2457452
    [No Abstract]   [Full Text] [Related]  

  • 4. Routine maternal serum alpha-fetoprotein testing.
    Ganiats T
    J Fam Pract; 1988 Nov; 27(5):465, 469, 550. PubMed ID: 2461426
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against].
    Kristoffersson U; Nørgaard-Pedersen B
    Lakartidningen; 1995 Mar; 92(12):1205-6, 1211-2. PubMed ID: 7535873
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenatal screening for open neural tube defects and Down syndrome: three decades of progress.
    Wald NJ
    Prenat Diagn; 2010 Jul; 30(7):619-21. PubMed ID: 20572104
    [No Abstract]   [Full Text] [Related]  

  • 7. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum alpha-fetoprotein screening.
    Reed BD; Ratcliffe S; Sayres W
    J Fam Pract; 1988 Jul; 27(1):20, 22, 26. PubMed ID: 2455763
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical significance of low maternal serum alpha-fetoprotein in obstetric practice.
    Sowers SG; Burton BK
    Birth Defects Orig Artic Ser; 1982; 18(3 Pt A):181-4. PubMed ID: 6181823
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha-fetoprotein. ACOG Technical Bulletin number 154--April 1991.
    Int J Gynaecol Obstet; 1992 Jul; 38(3):241-7. PubMed ID: 1280604
    [No Abstract]   [Full Text] [Related]  

  • 11. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on the relationship between elevated maternal serum fetoprotein and abnormal pregnancy in Taiyuan District].
    Zheng ZQ; Ma AY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):106-8. PubMed ID: 6190541
    [No Abstract]   [Full Text] [Related]  

  • 13. Maternal alpha-fetoprotein screening.
    Br Med J (Clin Res Ed); 1981 Dec; 283(6306):1604-5. PubMed ID: 6171323
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal alpha fetoprotein screening.
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1053-4. PubMed ID: 6170380
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of alpha-fetoprotein prenatal testing.
    Macri JN
    Prog Clin Biol Res; 1980; 44():47-63. PubMed ID: 6156466
    [No Abstract]   [Full Text] [Related]  

  • 16. Current issues in maternal serum alpha-fetoprotein screening.
    Bock JL
    Am J Clin Pathol; 1992 Apr; 97(4):541-54. PubMed ID: 1372789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
    Neveux LM; Palomaki GE; Larrivee DA; Knight GJ; Haddow JE
    Prenat Diagn; 1996 Dec; 16(12):1115-9. PubMed ID: 8994247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple of the median and its uses in antenatal screening].
    Jiangsu Province Birth Planning Commitee
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):428-9. PubMed ID: 15312334
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme.
    Crossley JA; Berry E; Aitken DA; Connor JM
    Prenat Diagn; 1996 Nov; 16(11):1039-42. PubMed ID: 8953638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.